MRCP2-1386
A 55-year-old male presents to the endocrine clinic for his annual review. Six years ago, he was diagnosed with a large pituitary tumor after experiencing visual field defects. He underwent successful surgical removal of a non-functioning pituitary tumor and received cranial irradiation radiotherapy. postoperative assessment revealed partial hypopituitarism, and he has been managing well on hydrocortisone 10 mg BD and thyroxine 150 µg daily since then. However, he has noticed a lack of libido. Serial MRI scans have shown no recurrence of the tumor.
The endocrine nurse performed some investigations prior to the clinic, and the results are as follows: random serum cortisol 768 nmol/L (120-600), free T4 21.2 pmol/L (10-22), TSH <0.05 mU/L (0.4-5), LH 1.1 mU/L (1-10), FSH 0.5 mU/L (1-10), IGF-1 7.8 nmol/L (18-37), and testosterone 7 nmol/L (9-35). Additionally, a DEXA scan requested by the SpR at the last appointment revealed average T scores of −2.3 and −2.1 at the hip and spine, respectively. What is the most appropriate treatment to prevent the progression of his bone loss?